• LEE011 Succinate: CDK4/6 Research Guide

  2026-08-16

  LEE011 succinate is a selective CDK inhibitor used to study CDK4/6-dependent cell cycle regulation and cancer-cell proliferation. Its pH-dependent solubility profile supports careful media, vehicle, and assay-control design in cancer research.

• EV-Based Targeted Degradation of Extracellular Proteins

  2026-08-15

  The reference study establishes an extracellular vesicle-based targeted protein degradation platform that uses autophagy-related recognition rather than target-cell surface receptors. By combining an SQSTM1 LIR degradation signal with target-binding domains, the platform degraded TNF-α and IL-1β simultaneously and reduced inflammation in rat and goat models of intervertebral disc degeneration.

• AAPH and Ferroptosis: Designing Better Assays

  2026-08-14

  AAPH enables controlled peroxyl-radical stress for erythrocyte hemolysis, lipid peroxidation, and antioxidant studies. This article explains how to use AAPH as a mechanistic stress input while interpreting membrane-repair biology through the PRDX6–GPX4 ferroptosis framework.

• Molidustat: From HIF Biology to Assay Design

  2026-08-14

  Molidustat (BAY85-3934) is a HIF-PH inhibitor whose activity connects oxygen sensing, endogenous erythropoietin stimulation, and renal anemia research. This assay-focused guide explains how 2-oxoglutarate dependence and VHL-mediated HIF-1α degradation should shape experimental interpretation.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-08-13

  Learn how to use the HyperScribe All in One mRNA Synthesis Kit for reproducible ARCA-capped, polyadenylated transcripts in translation, RNAi, and vaccine-development workflows. Practical setup guidance, assay-specific optimization, and troubleshooting connect bench-scale RNA production with spleen-targeted neoantigen vaccine research.

• Sulfo-Cy5 NHS Ester for Reliable Cell Assays

  2026-08-13

  Sulfo-Cy5 NHS ester (SKU A8108) supports aqueous-phase labeling of amine-containing biomolecules for sensitive fluorescence imaging alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide connects spectral properties, workflow controls, storage, interpretation, and vendor selection to more reproducible laboratory decisions.

• MLN2238: Proteasome β5 Inhibition Workflows

  2026-08-12

  MLN2238 enables controlled, reversible chymotrypsin-like proteasome inhibition for apoptosis, proteotoxic-stress, and drug-resistance studies. This workflow-focused guide connects biochemical target engagement with CREB/ROS/JNK readouts and practical oncology applications in multiple myeloma and lymphoma models.

• Biotin-HPDP for Thiol-Specific Protein Labeling

  2026-08-12

  Biotin-HPDP combines selective thiol chemistry with a reversible disulfide linkage, enabling affinity capture, release, and redox-sensitive protein analysis. Its workflow is especially useful for validating CD36 palmitoylation and related microglial mechanisms highlighted in Alzheimer’s disease research.

• Cy7 NHS Ester: Practical Protein Labeling Guide

  2026-08-11

  Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared dye for bioimaging and amino-group labeling of proteins and peptides. It is useful when organic cosolvents could compromise a delicate biomolecule, but working solutions should be prepared promptly and the reagent should not be selected when long-term solution storage or unvalidated in vivo performance is required.

• l-Phe Nanostructures Sensitize Tumors to ICB

  2026-08-11

  This Nature Nanotechnology study shows that metal-ion-chelating l-phenylalanine nanostructures can remodel immune dysfunction by regulating dendritic-cell electrophysiology, inflammasome activity, and NF-κB signaling. When combined with short-term starvation, the nanostructures enhanced dendritic-cell maturation and tumor-specific cytotoxic T-cell responses, thereby sensitizing breast and colorectal tumors to immune checkpoint blockade.

• Gemcitabine Beyond Cytotoxicity: A DDR Strategy

  2026-08-10

  A mechanism-first guide to positioning Gemcitabine in translational cancer research, connecting replication-stress biology, checkpoint signaling, apoptosis assays, and insights from lycorine-driven metabolic research.

• Sulfo-NHS-Biotin Maps CADASIL Vascular Signaling

  2026-08-09

  The NOTCH3 R545C CADASIL model links vascular injury to blood-brain barrier disruption, neuroinflammation, and impaired hippocampal plasticity. This thought-leadership article explains how Sulfo-NHS-Biotin can help translational researchers convert those findings into testable cell-surface proteome and protein-interaction studies while preserving the distinction between mechanistic evidence and workflow opportunity.

• JC-1 and the Next Layer of Tumor Immunity

  2026-08-08

  A translational framework for using mitochondrial membrane potential as a mechanistic bridge between redox-driven tumor immunomodulation, apoptosis biology, and development decisions.

• Biotin-HPDP for Palmitoylation Assays

  2026-08-07

  Biotin-HPDP enables reversible thiol-specific labeling for affinity enrichment and modification analysis. This article develops an assay decision framework linking its chemistry to CD36 palmitoylation, microglial biology, and S-nitrosylation research.

• NHS-Biotin: Precision Biotinylation for Protein Engineering

  2026-08-07

  NHS-Biotin (N-hydroxysuccinimido biotin) enables rapid, stable, and site-specific labeling of antibodies and proteins, unlocking advanced workflows for detection, purification, and multimeric nanobody assembly. Its unique membrane-permeability and short spacer arm make it ideal for both intracellular and extracellular protein engineering, as demonstrated by recent innovations in peptidisc-assisted nanobody clustering.

16892 records 1/1127 page Next 12345 下5页 Last page